Announced

Completed

Tenzing Acquisition completed the merger with Reviva Pharmaceuticals in a $62m deal.

Synopsis

Tenzing Acquisition, a special purpose acquisition company incorporated in the British Virgin Islands, completed the merger with Reviva Pharmaceuticals, a California-based clinical stage pharmaceutical company, in a $62m deal. "The execution of the merger agreement presents an important milestone and represents a unique opportunity to finance and advance the clinical development of Reviva's innovative therapies, which may improve treatment options for neuropsychiatric and respiratory diseases with high unmet medical needs," Laxminarayan Bhat, Reviva Founder, President and CEO.

Show Details & Financials

Did you work on this deal?

Claim Deal

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Claim Deal

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Tenzing Acquisition completed the merger with Reviva Pharmaceuticals in a $62m deal.